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Abstract  
Characteristics of the spreads of platelet-rich plasma (PRP) are 
not widely known despite commonly use. This study aims to 
evaluate whether PRP stays within the injected area by using 
ultrasonography, to improve understanding of the spreads of 
intratendinous injected PRP. Thirty-nine patients (15 males, 24 
females; mean age, 49.3 years), who had symptoms on their 
elbows (> 6 months) and diagnosed as lateral (25 elbows) or 
medial (14 elbows) tendinopathies of elbow, were included. The 
severity of tendon pathology was assessed by ultrasonography 
as tear or no tear. Immediately after ultrasound-guided PRP 
injection, ultrasound images were evaluated to assess the area of 
PRP distribution, which was defined as the presence of fluid or 
microbubbles. Ultrasound revealed that 13 elbows had tendon 
tear and 26 had no tear, respectively. Post-injection ultrasound 
confirmed the injected PRP was within the tendon in all cases. 
The mean distance of distribution from the injection site was 
12.6 mm (5.0–26.0 mm). There was no difference in the dis-
tance of PRP distribution between tendon tear and no tear. In-
jected PRP spread to soft tissue outside the tendon in 20 of 39 
cases. Intra-articular extension of PRP was observed in 5 cases. 
Although PRP remained intratendinous after the injection in all 
cases, some portion tended to spread outside from the injection 
site in a short space of time. Postinjection ultrasonographic 
imaging has a value for observing the spreading patterns of 
intratendinous PRP injection. 
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Introduction 
 
Tendinopathy is characterized by micro-tears of collagen 
fibers due to repetitive overuse and scarring. Once tendi-
nopathy occurs, it adversely affects function and increases 
the risk of re-injury. Furthermore, because of their poor 
vascularization, tendons have poor healing properties and 
heal more slowly compared to other connective tissues 
(Fenwick et al., 2002; Hayem, 2001). The major histolog-
ic characteristic of chronic tendinopathy is not inflamma-
tion but rather angiofibroblastic degeneration (Edwards 
and Calandruccio, 2003; Mishra and Pavelko, 2006). 
Therefore, new treatment options including dry needling, 
prolotherapy, and extracorporeal shockwave therapy are 
used to embrace inflammation rather than suppress it 
(Sampson et al., 2008).  
Platelet-rich plasma (PRP) is a fraction of autolo-
gous blood that has a platelet concentration above the 
autologous blood from which it was derived. PRP aids 
healing in response to musculoskeletal trauma (Foster et 
al., 2009). PRP contains high levels of growth factors, 
which play important roles in tissue healing; these factors 
include transforming growth factor-β1, insulin-like 
growth factors 1 and 2, vascular endothelial growth fac-
tor, basic fibroblast growth factor, and hepatocyte growth 
factor (Alsousou et al., 2009; Molloy et al., 2003). 
Growth factors influence the cellular processes for tissue 
repair, facilitate healing by activating intracellular signal 
pathways via binding growth factor receptor, and play 
important roles in revascularization (Tabata, 2004).  
PRP is obtained by sequestering and concentrating 
platelets using gradient density centrifugation (Marx et 
al., 1998). As a concentrated source of autologous plate-
lets, PRP contains several different platelet-derived 
growth factors and other cytokines that promote soft tis-
sue and bone healing. Autologous PRP was first used in 
the field of oral and maxillofacial surgery (Anitua, 1999; 
Marx et al., 1998) and has also been widely used in the 
other fields (Everts et al., 2007; 2008; Radice et al., 2010; 
Sampson et al., 2008). Injection is the preferred method to 
administer PRP into the injured tendon and various inject-
able PRP preparations are available for the management 
of various tendinopathies. PRP injection is increasingly 
being used as a regenerative therapy to treat tendinopa-
thies. PRP can be used in the treatment of chronic non-
healing tendon injuries, including the lateral and medial 
epicondylar, patellar, and Achilles tendons, among others. 
Several studies demonstrate PRP injection has beneficial 
effect on tendinopathy of elbow (Gosens et al., 2011;  
Mishra and Pavelko, 2006; Nguyen et al., 2011; 
Peerbooms et al., 2010). However, its effectiveness re-
mains controversial, because only a few high-quality 
randomized controlled trials have evaluated PRP for the 
treatment of tendinopathy of elbow (Krogh et al., 2013). 
Ultrasound-guided injection makes more sophisti-
cated delivery possible by enabling the visualization of 
the injected products in the region of tendon injury 
(Loftus et al., 2012). Because the core premise of PRP is 
to increase the concentrations of active cellular compo-
nents at the injury site, it is important to determine how 
much of the delivered PRP actually stays at the injection 
site and how much is distributed into the surrounding 
tissues. However, there are only a few reports about the 
post-injection distribution of PRP products (de Vos et al., 
2010; Loftus et al., 2012). 
Characteristics of the spreads of platelet-rich plas-
ma (PRP) are not widely known despite commonly use. 
This study aims to evaluate whether PRP stays within the 
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injected area by using ultrasonography, to improve under-
standing of the spreads of intratendinous injected PRP. 
 
Methods 
 
Participants 
Patients with elbow pain who had visited the outpatient 
clinic of a university hospital between June 2013 and 
February 2015.  
Inclusion criteria were as followed, (1) more than 
6 months of elbow pain; (2) pain score of the affected 
elbow greater than 4 on the visual analog scale (from 0–
10); (3) diagnosis of tendinopathies of elbow; and (4) no 
or little response to conservative care for at least 3 
months. The exclusion criteria were as followed: (1) pres-
ence of another diagnosis of elbow, such as fracture, 
rheumatologic or neurologic diseases; (2) any  prior sur-
gery of the elbow region; (3) history of any injections on 
affected elbows, such as steroid or prolotherapy, within 3 
months prior to visit; (4) unstable medical condition or 
known uncontrolled systemic diseases. This study was 
approved by the hospital’s institutional review board, and 
written informed consent was obtained from all partici-
pants after they were briefed about the study’s purpose 
and examination procedures. 
 
Procedure 
A physiatrist with 11 years of musculoskeletal ultrasonog-
raphy experience performed ultrasound-guided PRP injec-
tion and ultrasonographic examinations of the affected 
elbow before and after the procedure. All examinations 
were performed using an Antares ultrasound scanner 
(Siemens, Berlin, Germany) with a 5–13-MHz multifre-
quency linear transducer. All PRP products were prepared 
using the sPRP kit (Huons Inc., Seoul, Korea). Ultraso-
nography of the tendons of the elbow was performed 
before the injection to plan the specific site for PRP and 
obtain baseline images. The severity of tendon pathology 
was assessed by ultrasonography as tear or no tear.   
For PRP preparation, 20 mL venous blood was 
drawn from the antecubital vein using an aseptic tech-
nique and mixed with the anticoagulant citrate phosphate 
dextrose adenine (CPDA-1). The blood was subsequently 
placed into the PRP kit and centrifuged for 3 minutes at 
3,200 rpm to separate it into platelet-poor plasma, red 
cells, and PRP. The platelet-poor plasma was extracted 
via a special port and discarded from the device. After  
blood was collected, 1.5 mL PRP was made and used for 
injection. 
Using a sterile technique with a sterile probe cov-
er, real-time ultrasound guidance was provided during the 
PRP injection procedure. A sterile field was set up and 
maintained throughout the procedure. Before PRP admin-
istration, single fenestration by 23-gauge needle was 
performed under ultrasound guidance into affected ten-
dons at the lateral or medial epicondyle of the elbow. 
Needle tip was positioned at the region of tendinopathy 
and PRP (1.5 mL) was subsequently injected. Longitudi-
nal ultrasound images during the injection were obtained 
to   verify  the    injection   site.   Additional   longitudinal    
and transverse ultrasonographic images were scanned 5 
minutes after injection to assess the area of PRP distribu-
tion. The patients were instructed not to move their el-
bows or wrists until finishing additional ultrasonographic 
scan. To measuring the distribution distance after needle 
removed, the site of needle tip was marked on the skin 
during the injection.  
 
Imaging analysis 
Pre- and post-injection images were reviewed to evaluate 
PRP distribution independently by 2 authors with 19 and 
9 years of musculoskeletal ultrasonography experience, 
respectively. Injected PRP was considered to be 1) aggre-
gated within the tendon, 2) along the outer layer of ten-
don, or 3) diffused into the surrounding soft tissues or an 
adjacent joint after injection. The distribution of PRP was 
determined according to the presence of fluid or mi-
crobubbles after injection. The greatest distance was 
measured from needle tip to fluid/microbubbles. Intra-
articular extension was defined by the presence of new 
microbubbles or fluid that was not present in pre-injection 
images.  
 
Statistical analysis 
SPSS version 18.0 (SPSS Inc., Chicago, IL, USA) was 
used for statistical analysis. The Mann–Whitney U-test 
was used to compare the distribution of injected PRP with 
respect to the location of the tendon or tendon pathology. 
The level of significance was set at p < 0.05. 
 
Results 
 
The study population comprised 39 patients including 15  
male (38.5%) and 24 female(61.5%) patients with a mean 
age 49.3 years (range, 29–61 years). Three patients were 
excluded because steroid injections had been done to 2 
patients and prolotherapy to one. There were 25 (64.1%) 
and 14 (35.9%) cases of tendinopathies in lateral and 
medial elbow, respectively. Mean symptom duration was 
20.7 months (range, 6–28 months). Pre-injection ultraso-
nographic evaluation showed that there were 13 (33.3%) 
cases with tear and 26 (66.7%) cases with no tear. 
All 39 cases were considered adequate for evaluat-
ing the distribution of injected PRP on ultrasonographic 
images. The ultrasonographic images verified the injected 
PRP within the common extensor/flexor tendon in all 
cases. Figure 1 shows ultrasound images of the common 
extensor tendon during the PRP injection procedure. 
The mean (± SD) distance of PRP from the injec-
tion site was 12.6 ± 5.7 mm (range, 5.0–26.0 mm). There 
was no significant difference in the mean distance be-
tween injections to the common extensor tendon (13.4 ± 
5.6 mm) and common flexor tendon (11.9 ± 6.5 mm) (p = 
0.604). The mean distance of PRP post-injection did not 
differ significantly in cases in which the tendon had torn 
(13.0 ± 4.3 mm) or not (12.9 ± 6.4 mm) (p = 0.588). In-
jected PRP spread to soft tissue outside the tendon in 20 
of 39 cases. Intra-articular extension of injected PRP was 
observed in 5 cases; consisting of 3 cases had tendon tear 
and 2 had no tear, respectively (Figure 2). 
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Figure 1. Ultrasonographic findings of the common extensor tendon in a 44-year-old woman during PRP injection  
A. Longitudinal image showing amorphous hyperechoic calcification (arrow) and a partial-thickness tear (arrow head) in the com-
mon extensor tendon. B. Longitudinal power Doppler image showing increased vascularity around a calcification (arrow) and partial-
thickness tear (arrow head) in the common extensor tendon. C. Longitudinal image showing the needle tip (star) located in the area 
of a partial-thickness tear. D. Post-injection ultrasonographic image showing injected PRP (arrow) spread within the tendon; the star 
indicates the injected needle. E. Image 5 minutes post-injection showing some of the injected PRP remaining (arrow) near the injec-
tion site (star) and the rest extending up to 1.72 mm (arrowhead) beyond injection site surrounding soft tissues. LE: lateral epicondyle 
of the humerus, RH: radius head. 
 
Discussion 
 
In the present study, 1.5 mL injected PRP spread a mean 
of 12.6 mm from the injection site. And 20 out of 39 
(51%) subjects showed soft tissue spread beyond tendon 
and even extension to joint space was observed in 5 out of 
39 cases. There was no difference between common flex-
or tendon and common extensor tendon. Tendon tear did 
not affect the distance of distribution. These findings 
suggest that injected PRP tends not to stay at the injection 
site and rather diffuses away from it, regardless of the 
conditions such as kind of tendon, severity of tendon 
pathology, presence of inflammation. Similarly, in anoth- 
er study for chronic elbow tendinopathy, 3.5 mL injected  
PRP diffused > 20.0 mm from the injection site in most 
cases (48 of 49, 98%) and diffused into the adjacent soft 
tissue in 25 of 49 (51%) cases (Loftus et al., 2012).  Alt-
hough smaller volume (1.5 ml) of PRP was injected in 
present study such as previous study (Mishra and Pavelko, 
2006; Peerbooms et al., 2010), the proportion of spread 
beyond tendon was similar with the study of Loftus et al. 
(2012)  used 3.5 ml of volume.  
Though in all cases fluid also remained at the in-
jection site, some fluid diffuses out of the tendon in many 
cases indeed. The patients’ motion might be another ex-
planation that the remaining fluid diffuses out of the ten-
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don (so after 5 minutes in the present study). If the inject-
ed PRP spreads from target area like these results, we 
cannot evaluate the precise effect of injected PRP, be-
cause it is difficult to predict how many growth factors 
contained in PRP will stay in the degenerated area of the 
tendon. In order to administer sufficient growth factor 
with PRP injections, greater volume of PRP could be an 
option. However, greater volume can lead to further diffu-
sion and require much more blood collection, which is 
undesirable. The solidification of PRP helps it remain at 
the injection site long enough to heal the damaged tendon 
of shoulder (Rha et al., 2013). Calcium chloride and bo-
vine thrombin are combined with PRP to form a gel ma-
trix; they are usually used in surgical applications for 
grafting or intra-articular injections (Sampson et al., 
2008). If these exogenous activators can be used to treat 
tendinopathies of the elbow, the amount of growth factors 
maintained close to injection site could be potentially be 
maintained for a long time. 
 
 
 
 
 
 
 
Figure 2. Intra-articular extension of injected PRP.  
Longitudinal ultrasonographic image showing the injected PRP extend-
ing beyond the injection site (star) to the surrounding soft tissues (arrow) 
and within the elbow joint (arrowhead). LE: lateral epicondyle of the 
humerus, RH: radius head. 
 
Loftus et al. (2012) showed that the injected PRP 
extended beyond the injection site and frequently diffused 
along the tendon or peritendinous soft tissues in their 
study. The authors had indicated that a single puncture 
may be adequate whereas a peppering technique per-
formed in a blind injection was not necessary for exten-
sive delivery (Loftus et al., 2012). The results of this 
study were very similar with ours; however they had 
focused on the efficiency of injection technique and con-
cluded that single puncture was enough to deliver PRP 
rather than peppering technique in blind injection. In our 
study, we had used ultrasonographic injection technique 
and the accuracy of injection was regarded to be guaran-
teed. Therefore we had concentrated how far diffuse the 
injected PRP. Some studies have called into question the 
efficacy of PRP injections because the duration the plate-
lets remain at the site after injection into the degenerated 
area was not enough and platelets were slowly activated 
by exposure to tendon collagen (Mishra et al., 2009) (de 
Vos et al., 2010). The pressure within the tendon may 
cause a large amount of PRP to diffuse rapidly out of the 
tendon, thereby reducing its effect (de Vos et al., 2010). 
As the results of our study, unexpected distribution of the 
injected PRP to extratendinous soft tissue or joint space 
can reduce the effect of PRP. As our knowledge, exoge-
nous activators had not been used for chronic elbow ten-
dinopathy. Therefore, further studies are required to veri-
fy the effects of exogenous activators in the treatment of 
tendinopathies of the elbow. The main limitations of the 
present study are the small sample size, and heterogeneity 
of the subjects. And another limitation is that the study is 
not controlled and that the follow-up period was very 
short. These limitations made that causal relationships 
cannot be determined. Further studies are required to 
confirm whether PRP spread after injection correlate with 
the clinical outcome, and how long the exogenous activa-
tor such as calcium chloride and bovine thrombin can 
keep the injected PRP within the target area.   
	
Conclusion 
 
Although PRP remained intratendinous after the injection 
in all cases, some portion tended to spread outside from 
the injection site in a short space of time. Postinjection 
ultrasonographic imaging has a value for observing the 
spreading patterns of intratendinous PRP injection. 
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Key points 
 
 This study aims to evaluate whether PRP stays 
within the injected area by using ultrasonography, 
to improve understanding of the spreads of in-
tratendinous injected PRP. 
 Although PRP remained intratendinous after the 
injection in all cases, some portion tended to spread 
outside from the injection site in a short space of 
time. 
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